Jasper Therapeutics, Inc.JSPRWNASDAQ
Loading
Debt to Equity Over TimeNormalizing
Percentile Rank40
3Y CAGR-10.9%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
-10.9%/yr
Annual compound
Percentile
P40
Within normal range
vs 3Y Ago
0.7x
Contraction
Streak
2 yr
Consecutive declineNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 0.03 | -17.2% |
| 2023 | 0.04 | -65.0% |
| 2022 | 0.10 | +144.5% |
| 2021 | 0.04 | +189.8% |
| 2020 | -0.05 | - |
| 2019 | 0.00 | - |